HEMODYNAMIC EVALUATION WITH DYNAMIC DSA DURING THE TREATMENT OF CEREBRAL VASOSPASM - A RETROSPECTIVE STUDY

被引:14
|
作者
TOUHO, H
机构
[1] Department of Neurosurgery, Osaka Neurological Institute, Osaka
来源
SURGICAL NEUROLOGY | 1995年 / 44卷 / 01期
关键词
DELAYED CEREBRAL VASOSPASM; DIGITAL SUBTRACTION ANGIOGRAPHY; ENDOVASCULAR TREATMENT; MEAN TRANSIT TIME; SUBARACHNOID HEMORRHAGE;
D O I
10.1016/0090-3019(95)00069-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND Percutaneous transluminal angioplasty (PTA) and super-selective intra-arterial infusion of papaverine have recently been performed for the treatment of cerebral arterial vasospasm, with generally favorable results in patients with delayed symptomatic cerebral vasospasm. METHODS We used dynamic digital subtraction angiography (dynamic DSA) to measure local transit time before and after endovascular treatment (EVT) for the treatment of ruptured intracranial aneurysm and delayed symptomatic cerebral vasospasm. Mean transit time (MTT) was measured by dynamic DSA in 19 patients with ruptured intracranial aneurysm and delayed symptomatic cerebral vasospasm and 6 patients without symptomatic cerebral vasospasm (group III) just after surgery, immediately prior to EVT, just after EVT, and in the chronic stage of disease more than 1 month after onset of subarachnoid hemorrhage. EVT included PTA using a silicone nondetachable balloon and/or superselective infusion of 0.2% papaverine. RESULTS Symptomatic vasospasm occurred between days 7 and 11 after onset of subarachnoid hemorrhage. The MTT just after the onset of neurologic deterioration in these 10 patients with complete neurologic recovery during the chronic stage of disease (group I) and the other 9 patients without complete recovery (group II) were respectively 6.92 +/- 0.42 seconds and 7.66 +/- 0.78 seconds. The latter value was significantly larger than the former (p < 0.02). MTT just after EVT in group II were also significantly greater than the corresponding MTT in group I (p < 0.002). In addition, immediately prior to EVT the MTT in group I and group II was significantly longer than that in group III (p < 0.0001). CONCLUSIONS Functional analysis with dynamic DSA can be used to detect hemodynamic disturbances, and can be used for hemodynamic evaluation during the treatment of symptomatic cerebral vasospasm.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 50 条
  • [1] HEMODYNAMIC EVALUATION WITH DYNAMIC DSA DURING THE TREATMENT OF CEREBRAL VASOSPASM - A RETROSPECTIVE STUDY - COMMENTARY
    DEBRUN, G
    SURGICAL NEUROLOGY, 1995, 44 (01): : 73 - 74
  • [2] Hemodynamic Effect of Cerebral Vasospasm in Humans: A Modeling Study
    Carlo Alberto Lodi
    Mauro Ursino
    Annals of Biomedical Engineering, 1999, 27 : 257 - 273
  • [3] Hemodynamic effect of cerebral vasospasm in humans: A modeling study
    Lodi, CA
    Ursino, M
    ANNALS OF BIOMEDICAL ENGINEERING, 1999, 27 (02) : 257 - 273
  • [4] Assessment of cerebral microcirculatory changes during cerebral vasospasm by analyzing cerebral circulation time on DSA images
    Ohkuma, H
    Ogane, K
    Tanaka, A
    Suzuki, S
    CEREBRAL VASOSPASM, 2001, 77 : 127 - 130
  • [5] Hemodynamic consequences of cerebral vasospasm on perforating arteries - A phantom model study
    Soustiel, JF
    Bibi, R
    Lukaschuk, S
    Manor, D
    STROKE, 2001, 32 (03) : 629 - 635
  • [6] Evaluation of the Effect of Asiatic Acid on Cerebral Vasospasm An Experimental Study
    Akyuz, Mehmet Emin
    Sahin, Mehmet Hakan
    Kadioglu, Hakan Hadi
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2021, 43 (06): : 633 - 640
  • [7] Evaluation of cerebral vasospasm with transcranial magnetic stimulation:: an experimental study
    Göksel, HM
    Akgun, M
    Topalkara, K
    Solak, O
    Topaktas, S
    CLINICAL AND EXPERIMENTAL MEDICINE, 2001, 1 (01) : 43 - 49
  • [8] Evaluation of cerebral vasospasm with transcranial magnetic stimulation: an experimental study
    H.M. Göksel
    M. Akgün
    K. Topalkara
    O. Solak
    S. Topaktaş
    Clinical and Experimental Medicine, 2001, 1 : 43 - 49
  • [9] Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study
    Onichimowski, Dariusz
    Nosek, Krzysztof
    Goraj, Radoslaw
    Jalali, Rakesh
    Winska, Aleksandra
    Pawlos, Aleksandra
    Tuyakov, Bulat
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1777 - 1783
  • [10] Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment
    Albanna, Walid
    Weiss, Miriam
    Conzen, Catharina
    Clusmann, Hans
    Schneider, Toni
    Reinsch, Martin
    Mueller, Marguerite
    Wiesmann, Martin
    Hoellig, Anke
    Schubert, Gerrit Alexander
    WORLD NEUROSURGERY, 2017, 102 : 459 - 465